SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. The company was selected from a field of ten finalists, which included established medical technology companies such as Intuitive, Johnson & Johnson MedTech, Medtronic, and others. The award recognizes commercial performance, technological innovation, societal impact, customer recognition, ethical standards, and workplace practices.
Chairman and Chief Executive Officer Dr. Sudhir Srivastava said the award reflects the company’s focus on expanding access to robotic surgery while continuing to develop technologies intended to improve affordability for hospitals and healthcare systems. The recognition provides an independent industry endorsement as SS Innovations expands its presence in the global surgical robotics market.
The award coincides with continued operational growth for the company’s flagship SSi Mantra surgical robotic platform. As of June 22, 2026, surgeons had completed a cumulative 11,719 multi-specialty procedures using the SSi Mantra system, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric operations. The platform has been used across more than 170 different types of surgical procedures, reflecting its use across multiple disciplines.
Training has expanded alongside system adoption. Approximately 2,100 physicians have completed training on the SSi Mantra platform, which is an important consideration for hospital purchasing decisions and long-term utilization of robotic surgery systems.
The company’s commercial footprint has broadened internationally, with regulatory approvals granted in 14 countries: Colombia, Ecuador, Guatemala, Guyana, India, Indonesia, Iraq, Kenya, Nepal, Oman, the Philippines, Sri Lanka, Ukraine, and the United Arab Emirates. These approvals support continued market expansion as healthcare systems evaluate robotic-assisted surgery.
SS Innovations describes the SSi Mantra as a modular, multi-arm robotic surgery platform designed to support multiple surgical specialties. The system incorporates between three and five robotic arms, a three-dimensional 4K visualization system, an ergonomic surgeon console, and digital imaging capabilities. Its instrument portfolio includes more than 40 robotic surgical instruments, including smaller 5-millimeter instruments intended for pediatric and ear, nose, and throat procedures.
The company has also developed a portable tele-surgeon console, known as the SSi MantrAsana, which supports remote surgical capabilities. SS Innovations has reported performing more than 20 cardiac telesurgeries using the platform.
For more information, visit the company’s website at www.SSInnovations.com.
